2024

1. A CD38/CD3xCD28 trispecific T-cell engager as a potentially active agent in multiple myeloma patients relapsed and/or refractory to anti-CD38 monoclonal antibodies

   British Journal of Haematology

2. A mouse model to assess immunotherapy-related colitis

   Methods in Cell Biology (Academic Press Inc.)

3. A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function

   European Journal of Heart Failure, Vol. 26, Núm. 4, pp. 707-729

4. AI is a viable alternative to high throughput screening: a 318-target study

   Scientific Reports, Vol. 14, Núm. 1

5. An atlas of cells in the human tonsil

   Immunity, Vol. 57, Núm. 2, pp. 379-399.e18

6. An automated network-based tool to search for metabolic vulnerabilities in cancer

   Nature Communications , Vol. 15, Núm. 1

7. Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/ MINOVA Study)

   Clinical Cancer Research, Vol. 30, Núm. 1, pp. 176-186

8. Analysis of the prognostic value of emergency blood tests in ischaemic stroke

   Neurologia, Vol. 39, Núm. 8, pp. 617-628

9. Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1

   JHEP Reports, Vol. 6, Núm. 1

10. Belantamab mafodotin: an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myeloma

    Haematologica

11. Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma

    Clinical Cancer Research, Vol. 30, Núm. 10, pp. 2085-2096

12. Biomaterials-Based Antioxidant Strategies for the Treatment of Oxidative Stress Diseases

    Biomimetics, Vol. 9, Núm. 1

13. Building on the clinical applicability of ctDNA analysis in non-metastatic pancreatic ductal adenocarcinoma

    Scientific Reports, Vol. 14, Núm. 1

14. CD137 (4-1BB) and T-Lymphocyte Exhaustion

    Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 30, Núm. 18, pp. 3971-3973

15. CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trials

    Nature Communications, Vol. 15, Núm. 1

16. Calbindin and Girk2/Aldh1a1 define resilient vs vulnerable dopaminergic neurons in a primate Parkinson’s disease model

    npj Parkinson's Disease, Vol. 10, Núm. 1

17. Characterization of brain transduction capability of a BBB-penetrant AAV vector in mice, rats and macaques reveals differences in expression profiles

    Gene Therapy, Vol. 31, Núm. 9-10, pp. 455-466

18. Circulating biomarkers of myocardial remodelling: current developments and clinical applications

    Heart, Vol. 110, Núm. 19, pp. 1157-1163

19. Comparison of assays measuring extracellular vesicle tissue factor in plasma samples: communication from the ISTH SSC Subcommittee on Vascular Biology

    Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 10, pp. 2910-2921

20. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports